The U.S. Patent and Trademark Office has issued a patent to ADMA Biologics for methods of treatment and prevention of S. pneumonia infection.
An NIH research team has determined how several antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory.
FDA has given Sanofi SA’s dengue vaccine Dengvaxia a narrow approval since the vaccine can cause severe infections in some people.
The National Meningitis Association has launched a campaign to encourage more teens to get the meningitis booster.
FDA has approved an expanded indication for Dova Pharmaceuticals’ Doptelet (avatrombopag) to treat adults with chronic immune thrombocytopenia.
A BYU study found introducing vaccine-hesitant people to people affected by vaccine-preventable diseases can decrease vaccine hesitancy.
Researchers at the University of Oxford in the United Kingdom have linked several genetic variations with the level of protective antibodies generated following routine childhood immunizations.
The 2018-19 influenza (flu) season was both the longest in a decade and marked by two separate waves of influenza A, CDC says.
Sanofi and Merck’s Vaxelis has been approved by the U.S. Food and Drug Administration.
A previously unknown autoimmune muscle disease involving sudden onset of debilitating muscle pain and weakness has been identified by researchers at Washington University School of Medicine in St. Louis, Mo.
A new study by researchers at Columbia University has found handing a pamphlet about influenza (flu) to parents in pediatricians’ waiting rooms can have a significant impact on increasing the uptake of the flu vaccine.
The U.S. Department of Health and Human Services released an additional $487 million to supplement first-year funding through its State Opioid Response grant program.
